Milestone Pharma says China NMPA approves etripamil nasal spray for PSVT in adults
MIST•China approval for etripamil nasal spray
Milestone Pharmaceuticals reported China’s NMPA cleared etripamil nasal spray for adult PSVT, its first approval outside the US.
Everest Medicines will commercialize the product in Greater China under an exclusive license.
Milestone payment triggered by clearance
The clearance triggers a USD 2 million milestone payment to Milestone; the deal includes up to USD 98 million in additional milestones.
